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Advanced flow cell design for in vitro release testing 
of mucoadhesive buccal films
Films for buccal application are a slowly emerging new 
platform for drug delivery. There remains a lack of analyti-
cal techniques for the determination of in vitro active phar-
maceutical ingredient release. The aim here was to develop 
an alternative method to the commonly used United States 
Pharmacopoeia (USP) 2 method, based on the flow-through 
cell. This system extends the release time and enables more 
detailed sample discrimination according to formulation. It 
could be used as a tool for in vivo prediction of drug release 
rates from buccal film formulations. The flow cell contains 
two chambers separated by a membrane through which the 
released active pharmaceutical ingredient is measured. Vital 
system variables and their effects on the release rate of the 
model active pharmaceutical ingredient are presented for 
formulations based on sodium alginate polymer. The method 
reflects the differences between films and is shown to be 
discriminatory for evaluation of buccal formulations.
Keywords: release rate, buccal films, hydrostatic pressure, 
flow cell
The oral route for drug delivery is the most desired way of drug administration in 
terms of patient compliance (1). Orally dispersible formulations that are easy to apply or 
act as instant release are being improved in terms of tablets and thin films. Indeed, films 
for the buccal application have been introduced and are gaining in popularity (2). Films 
can be adhesive to the mucosa and provide rapid drug release, with the drug absorbed 
from the oral cavity directly into the blood system (3, 4). The time between drug admini-
stration and effect taking place can be shortened and the first-pass metabolism can be 
avoided. Films are administered without water and are suitable for patients who are suf-
fering from dysphagia (5, 6). Films can be composed of multiple layers and facilitate drug 
release from both or only one side (7, 8). However, because of their unique properties, films 
are challenging for development and manufacture. There is a lack of suitable in vitro dis-
solution testing techniques for researchers to evaluate formulation's drug release rate 
properties (9). Research and development of films comprise a balance between appearance, 
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Release testing is a common tool to evaluate the properties of films in vitro (11). Many 
dissolution procedures have been described in pharmacopoeias, but none of these are 
suitable for film formulations (12). Conventional methods cause films to dissolve in a few 
minutes when there are large volumes of the dissolution medium and good liquid flow. 
Comparing the active pharmaceutical ingredient release profiles of two dissolving films 
typically does not provide discriminatory data, for example due to different composition. 
Therefore, the effect of the changing formulation composition on the drug release profile 
is difficult to assess.
In the present study, a method to extend release times and to express differences be-
tween film formulations was developed. Extending the release times helps to distinguish 
the formulations with a faster drug release rate. Release testing systems for films that are 
an alternative to pharmacopoeia tests have been introduced in many studies. Xia et al. in-
troduced a flow-through cell (12), where the film was positioned in the chamber of a flow 
cell. A constant flow of dissolution medium was maintained using a syringe pump. The 
samples eluted from the flow cell were collected and the drug release was quantified. Aliaa 
et al. used the US Pharmacopoeia (USP) apparatus II with the film fixed on a glass slab, to 
avoid floating of the formulation (13). The glass slab was used as a sinker and support, with 
the whole structure placed at the bottom of the dissolution vessel. 
Krampe et al. proposed a release method that used a filter frame in which the film was 
placed and pressed to the filter using a punch (14). This whole structure, including the 
punch, was placed in the USP apparatus II vessel and it floated on the surface of the disso-
lution medium. During mixing by the paddle, the drug release was determined at different 
times. Laitinen et al. proposed a release method that used a flow cell in which the film was 
placed (15). The dissolution medium was pumped in a closed loop through the cell using 
a peristaltic pump. Here, drug release was detected by reflectance measurements with a 
He-Ne laser beam that passed through the glass walls of the flow cell. There was thus no 
sampling needed, and the dissolution volume remained the same. 
Adrover and Nobili (16) and Adrover et al. (17) introduced a millifluidic flow-through 
device for film release testing. This consisted of a small flow cell (2 mm × 2.2 cm × 3 cm), a 
medium reservoir and a volumetric pump. The oral thin film was placed on the wall of the 
cell and was exposed to the dissolution medium from one side only. The medium was 
passed through the cell at a flow rate of 2 to 20 mL min–1, with samples taken from the 
eluted medium and analysed separately.
For all of these release rate techniques, only one side of the film was wetted during the 
testing. However, under in vivo conditions, the film is wetted from both sides. In the oral 
cavity, constant moisture is present and causes swelling of the polymer. Therefore, the film 
swells and erodes from the mucosa and the oral cavity side. In the present study, the dis-
criminatory method facilitates the release rate of buccal films from both sides.
EXPERIMENTAL
Materials
Na-alginate protanal 10/60 was purchased from FMC Health and Nutrition (USA). 
Tartrazine was purchased from Sigma Aldrich (USA), Xylitab 200 was donated by Danisco. 
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NaCl was purchased from Merck (Germany). Acetate cellulose membrane with pore size 
0.45 µm was purchased from Sartorius Stedim Biotech (France).
Preparation of the buccal films
The wet film solution contained 3 g sodium alginate, 2 g Xilitab 200, 0.2 g tartrazine 
and 90 g purified water. The Xylitab and tartrazine were initially mixed with the water to 
obtain a clear solution, and under rapid stirring (magnetic stirrer) the sodium alginate was 
added slowly. This was important to minimise aggregation of the sodium alginate parti-
cles and to accelerate its dissolution. Initially, an unclear suspension was formed, which 
cleared with constant mixing and heating to 60 °C. The solution was then sonicated for 10 
min to eliminate air bubbles. Subseqently, the solution was spread on glass plates (35 cm × 
35 cm) with an applicator (ZUA 2000; Zehnter, Switzerland), at different film thicknesses. 
The applicator settings of 1400 µm and 1800 µm were used. The glass plates with the films 
were then dried (SP-45; Kambič, Slovenia) at 65 °C for 90 min. The films obtained were cut 
into 2 cm × 3 cm pieces. 
Tartrazine assay
The tartrazine released from the films was measured with an ultraviolet-visible (UV-
VIS) spectrometer (8453 UV-visible spectrometer, Agilent, USA) at 425 nm. The medium 
used was 0.9 % NaCl solution, with the same technique used for evaluation of the release 
samples.
Release testing system
The release flow cell consisted of two chambers made of poly(methyl methacrylate) 
that were separated by an acetate cellulose membrane with 0.45 µm pore size. The cham-
bers were positioned one on top of the other. The chamber dimensions were 2 mm smaller 
than those of the film, for width and length. The film was placed in the upper chamber and 
held fixed by the edges of the chamber. The film was positioned in the donor chamber, on 
top of the membrane. The release flow cell is illustrated on Fig. 1. The donor chamber only 
had an input for the medium to enter the chamber. The acceptor chamber had an input and 
an output for the medium. The main goal was to keep constant higher pressure for the 
medium in the donor chamber so that the film was pressed onto the membrane. Constant 
pressure was maintained also in the acceptor chamber to ensure the flow of the medium 
through the acceptor cell. Constant liquid pressure was achieved by applying constant 
hydrostatic pressure to the chamber.
Fig. 1. The release flow cell design.
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The possibility of mass transfer resistance through the membrane and its effect on the 
drug release rate was taken into consideration. Therefore, a test film was dissolved in a 250 
mL of dissolution media and the solution was poured at the donor side. At the acceptor 
side samples were taken and concentration of model drug was measured at different time 
points.
The dissolution medium in a beaker was positioned at a higher level than the flow cell. 
This beaker and the flow cell were connected by a tube and the medium flowed through 
the tube and the cell due to the height difference. During the emptying of the beaker, the 
liquid level decreased, and thus the pressure in the cell also decreased. To ensure constant 
hydrostatic pressure, a levelling device had been developed. This device determined the 
liquid level in the beaker, with the position of the beaker adjusted as the medium level 
decreased. Thus, as the liquid level in the beaker decreased, it had moved upwards by the 
same height difference. The precision of the levelling device was 0.5 mm in both direc-
tions.
The release rate system consisted of two separate levelling devices, one for each cham-
ber (Fig. 2). The flow from the flow cell was collected in a reservoir that was constantly 
stirred by a magnetic stirrer. The system had a closed loop for the dissolution medium that 
flowed from the acceptor levelling beaker through the acceptor chamber into the reservoir. 
From the reservoir, the medium was pumped back to the acceptor levelling beaker using 
a peristaltic pump (503 S; Watson Marlow, England). The set-up of the release rate system 
Fig. 2. The constant levelling device for the control of the hydrostatic pressure delivered to the donor 
chamber. MCU – microcontroller unit, PC – personal computer.
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is shown in Fig. 3. The pump for the reservoir was started when the medium level in the 
levelling beaker reached its lowest, and it was stopped when the levelling beaker was full 
again. The total volume of medium at the start was 250 mL.
The medium that flowed through the donor chamber was always fresh and was not 
in the closed-loop system. The pressure applied to the donor chamber was higher than that 
for the acceptor chamber. However, the medium flow through the acceptor chamber was 
greater than of the donor chamber, due to the flow resistance of the membrane filter. The 
flow through the acceptor chamber was pre-set and kept constant, whereas the flow from 
the donor chamber changed with time, due to the dissolving of the film matrix. Thus, the 
dissolving of the film resulted in decreased flow resistance, although only for the medium 
in the donor chamber. Pressure in the donor chamber was about 1000 Pa greater than pres-
sure in the acceptor chamber. This pressure difference was important for the achievement 
of tight contact between the film and the supporting membrane. Because the acetate cel-
lulose membrane does not exhibit the same properties as human mucosa, the alginate 
films do not adhere to it. Therefore, the pressure difference maintained the film’s position 
and pushed the film against the membrane.
To maintain the desired temperature of the dissolution medium (37 ± 0.5 °C), a heat 
exchanger was used for the tubes through which the dissolution medium entered the flow 
cell. The temperature was thus controlled via a temperature sensor inside the acceptor 
chamber. The medium that carried the dissolved film components was collected in the 
reservoir, from which samples were taken. These sampling points were not time-based, 
but were event-based. Each time the acceptor chamber beaker became empty, a 10 mL 
sample was taken from the reservoir, with the sample volume replaced by fresh dissolu-
tion medium (de-aerated prior to use). The presence of air bubbles could cause fluctuation 
in the flow and pressure inside the flow cell. All of the temperature data and movements 
Fig. 3. Schematic depiction of the release system used.
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of the levelling device were collected for further evaluation. The whole process, including 
the sampling, was controlled through a computer, to minimise human error.
Each film used in the release process was precisely weighed before being placed care-
fully in the centre of the release cell. The film was covered by a membrane filter and the 
second cell block of the set-up, with the blocks tightened together firmly by four bolts. The 
flow cell containing the film was then fitted with the tubes and positioned in the stand (Fig. 
2), which held the cell and the outlet tube at the same height at all times. The height differ-
ence between the outlet tube, the medium level, and the flow cell defined the hydrostatic 
pressure in the cell.
In setting up, 250 mL dissolution medium was poured into the reservoir, and before 
the start of the release process, all of the tubes and both levelling beakers were filled with 
this dissolution medium. The medium flow was blocked using two valves, with the release 
process started by opening both of the valves, which also triggered the computer software 
for the data capture. The samples were taken from the reservoir automatically using an 
autosampler, and further analysed using a UV-VIS spectrometer. All parts of the release 
testing system were designed and built by our research team. 
Initial experiments
The first experiments were carried out to determine the importance of the wetting of 
the film from both sides during its release. In this situation, the film placed in the flow cell 
was isolated from the donor chamber by being covered with aluminium foil. This way it 
was no longer in contact with the medium on the donor (upper) side. Thus, the film swelled 
and dissolved only from the medium that was flowing through the acceptor chamber. 
Here, the donor chamber was filled with the medium as for the other release tests, where-
by the hydrostatic pressure of the medium pressed the aluminium foil and the film onto 
the membrane. This maintained all of the parameters the same as in the other release tests, 
to only define the effects of wetting of the film on one side only.
Variables in the release tests
The second series of release tests for these films included the combinations of changes 
in the measurement conditions, for the medium flow through the acceptor chamber (19, 25 
g min–1), the difference in height between the donor chamber medium level and the flow 
cell (333, 443 mm), and the mass of the films (40, 60 mg). The experimental designs for these 
conditions are given in Table I for the definition of the two factorial levels (–1, 1) and the 
three factors (A, B, C). Each of the eight conditions was repeated three times, to assess the 
Table I. Definition of the experimental design for the two factorial levels (–1, 1) and the three factors (A, B, C)
Condition Medium flow (mL min–1) Position of donor beaker (mm) Film mass (mg)
A B C
–1 19 333 40
1 25 443 60
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reproducibility. The mean release profiles and the coefficient of variation (CV) were calcu-
lated. This experimental design was used to study which factor had greatest effects on the 
release process, and to determine whether the release process was driven by the film 
proper ties and was not a result of the variability of the device settings. The liquid flow rate 
in the acceptor chamber was selected by two factors. The first reason was to mimic the 
blood flow rate in the buccal veins. Squier et. al. measured buccal flow rate 20.3 mL min–1 
per 100g of tissue (18). A second reason was to achieve sink condition on the acceptor side 
and prevent false time-delayed release detection.
Discrimination ability of the method
To assess the discrimination ability of the method, the dissolution profiles of the ex-
periments varying in one parameter were compared. The comparison was done according 
to the international guidelines with the model-independent approach. The release profiles 
included percent of released tartrazine at times 5, 10, 15, 20, 25, 30, 35, 45, 60 and 80 minutes. 
The similarity factor f2 was calculated. Only one measurement was considered after 85 % 
release of both instances. The 90 % confidence interval (CI) for f2 was calculated by boot-
strapping (n = 5000). Release profiles were accepted as similar if the lower CI of f2 was 
higher than 50. All calculations were performed using Excel add-in DDSolver (19).
RESULTS AND DISCUSSION
Testing of the mass transfer resistance showed that the membrane does not affect the 
model drug mass transfer to the acceptor chamber. Concentration increase did linearly 
correlate with the flow rate of the transferred media trough the membrane. Therefore, it 
seens reasonable to assume that the membrane does not affect the release profiles in a non-
constant manner and is appropriate for the release testing. Linear increase of the tartrazine 
amount in the reservoir is depicted in Fig. 4.
The release tests, where only the acceptor side of the film was wetted, provided some 
interesting data. With the inclusion of the aluminium foil on the donor side, the film 
Fig. 4. Permeation of the film solution through the membrane into the acceptor compartment.
366
B. Grilc et al.: Advanced flow cell design for in vitro release testing of mucoadhesive buccal films, Acta Pharm. 70 (2020) 359–371.
 
swelled only from the acceptor side which prolonged the release time of the incorporated 
colorant. Due to the fixed cell geometry, the colorant was released from a constant surface 
area. In the release profiles shown in Fig. 5, it can be seen that these two release profiles 
(i.e., ± aluminium foil) started similarly, and remained similar up to 33 min. At that time, 
the film colorant release rate without the aluminium foil increased more rapidly to reach 
100 % release at 94 min. The film isolated with the aluminium foil continued to dissolve 
with a slower colorant release rate. There are no inflection points on this colorant release 
curve with the aluminium foil, and it took 183 min to release 80 % of the colorant. After 
that time, the process was stopped. With the film wetted only from one side, it was not 
completely dissolved even after twice the release time compared to the film without alu-
minium foil, and wetted on both sides. Release profile comparison analysis showed sig-
nificant differences between profiles depicted in Fig. 5. A calculated model-independent 
similarity factor value is 29.9. Therefore, the wetting of the film on the donor side had a 
significant impact on the release rate.
Fig. 6 illustrates the data from all of the release experiments across eight different 
designs. All of these profiles followed specific sigmoid curves. Here, each profile started 
with almost constant release of the colorant, which then increased at some point during its 
release. This is visible as inflections in these curves. 
During this monitoring of the colorant release, the flow of the medium from the donor 
chamber to the acceptor chamber was tracked according to the movement of the levelling 
beaker. At the beginning of these release processes, none of the medium was lost from the 
beaker, which meant that no medium flowed from the donor to the acceptor chamber. 
Thus, in the beginning, the film represents a barrier for the medium to flow from the donor 
chamber to the acceptor chamber. Then the donor beaker flow rate started to increase with 
time in a non-linear manner. Here, it was expected that the increase in the donor chamber 
flow rate would correlate with the increase in the colorant release rate. However, the flow 
rate from the donor to the acceptor chamber did not start to increase until 100 % of the 
colorant had been released, as illustrated in Fig. 7.
These release profiles can be divided into three parts. In the first part, there was a 
semi-constant release rate for the colorant, due to the medium that flowed through the 
Fig. 5. Representative data for the release profiles of two films, with (foil) and without aluminium foil 
(no foil).
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acceptor chamber to wet the film on one side, through the membrane. The film then 
swelled and the colorant was constantly released and flushed into the acceptor reservoir. 
During this time, the film has been also swelling on the top, in the donor chamber, but 
because of the barrier that was formed, only the colorant from the bottom of the film was 
released into the acceptor chamber. In the second part, the medium penetrated more into 
the film and softened this barrier. The film then swelled to the point that it was pushed 
through the membrane by the medium pressure in the donor chamber. The dissolved film 
content was thus transferred to the acceptor chamber, where the medium flow flushed it 
into the reservoir. At this point, the release rate of the colorant was increased, which is 
visible as an inflection in the profile of the colorant release curve. During this release pe-
riod the film was penetrated and its resistance as a barrier to the flow from donor to acceptor 
chambers decreased. This resulted in increased flow rate from donor to acceptor, and con-
Fig. 6. Release profiles for all of the eight conditions (Table II) examined here. 
Fig. 7. Representative data for the tartrazine release rates compared to the flow of the medium from 
the donor chamber to the acceptor chamber.
368
B. Grilc et al.: Advanced flow cell design for in vitro release testing of mucoadhesive buccal films, Acta Pharm. 70 (2020) 359–371.
 
sequently, the film moved through the membrane and there was full release of the colorant 
from the film. The speed of this process was a reflection of the film’s properties. Using this 
type of release design allows observation of the swelling properties of the polymer. The 
inflection point on the release profile may represent the time at which the film is com-
pletely swollen. This is advantageous over the other release methods. Also, the acetate 
cellulose membrane could be easily changed by the etched mucosa for ex vivo studies and 
providing better insight into in vivo conditions.
The reproducibility of the experiments was satisfactory. The CV was less than 20 % 
for time points 15 min or less in all cases, except for the experiment 7 at 5 min (CV = 26 %). 
The CV was 10 % or less for time points higher than 15 min, with slightly higher variabil-
ity observed only in experiment 7. Nevertheless, the CV was never higher than 15 %. 
The results from the experimental design are given in Table II, where the time needed 
for 80 % of colorant release was used as the reference point for comparisons across the 
eight conditions. The factor effects were calculated using a factor analysis approach, 
whereby the biggest effect on film release time was the mass of the film. In the present case, 
the mass was directly proportional to the film thickness, because the films were cut to the 
same size of 2.0 cm × 3.0 cm, and thus we can interpret this mass factor as a film thickness 
factor. There were also large effects on the release time according to the position of the 
donor beaker. This was reduced in this design by 25 % from the original setting (i.e., from 
443 mm to 333 mm), which was defined as a significantly important factor. Hydrostatic 
pressure in a donor chamber is normally not changed between release tests. Here, it is 
shown that it is important to keep the height ratio constant for comparisons between for-
mulations. Surprisingly, the factor of the flow rate through the acceptor chamber was par-
ticularly low. This is a good result because variations in the flow will not influence the 
discriminatory properties of this method.
Table II. Design of the experiments carried out, and their factor effects on the film release rates
n
A B C










1 19 333 40 –1 –1 1 1 29
2 19 433 40 1 –1 –1 –1 20
3 19 333 60 –1 1 –1 –1 64
4 19 433 60 1 1 1 1 34
5 25 333 40 1 1 1 –1 31
6 25 433 40 –1 1 –1 1 19
7 25 333 60 1 –1 –1 1 63
8 25 433 60 –1 –1 1 –1 32
Effect 0.5 –20.5 23.5 1.0 1.0 –10.0 –0.5
t (80 %) – time needed for 80 % tartrazine release from the film.
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There were, however, minor differences between the release profiles. When there was 
a higher flow rate, the release time was a little shorter. Comparing profiles 2 and 6 or 3 and 
7 in Fig. 6, the effect of flow rate was smaller compared to the beaker position and film 
thickness. There was also a significant effect of the combined B × C factors. This indicated 
that it was potentially important to set the donor beaker position according to the film 
thickness to obtain the most discriminatory data. However, the major effects are related to 
the film properties, which are the main interest of this release method.
The calculated f2 similarity factors additionally confirm the above (Table III). The 
mass factor and the position of the donor beaker were significant parameters, considering 
the release profile comparison in these cases demonstrated significant differences. The 90 
% CI of f2 factors was below 50. Specifically, in the case of varying beaker position, the 90 
% CIs of f2 across all comparisons were between 26.9 and 36.8, which corresponds to the 
average difference between 18 and 30 %. When film mass was varied, the 90 % CI of f2 was 
between 22.4 and 29.0, which corresponds to the average difference between 25 and 35 %. 
In contrast, when the flow rate was varied, the lower CI of f2 was higher than 50 in all 
cases, thus accepting profiles as similar and the parameter as nonsignificant. The average 
difference of the release profiles obtained by varying the flow rate was within 10 %.
CONCLUSIONS
The drug release testing from a dosage form provides an insight into product perfor-
mance and obtained data could further guide the formulation development process. A 
discriminatory release method to evaluate buccal films was thus investigated. The pre-
Table III. Comparison of the release profiles
Pair
A B C






1-1 19 vs. 25 333 40 74.7 71.9 (56.7–89.8)
1-2 19 vs. 25 433 40 63.5 63.5 (51.4–73.3)
1-3 19 vs. 25 333 60 68.5 67.1 (53.0–85.9)
1-4 19 vs. 25 433 60 64.0 63.1 (50.2–74.8)
2-1 19 333 vs. 433 40 29.6 29.4 (26.9–32.6)
2-2 25 333 vs. 433 40 33.6 33.6 (31.0–36.8)
2-3 19 333 vs. 433 60 31.8 31.7 (28.5–35.1)
2-4 25 333 vs. 433 60 30.6 30.6 (27.7–33.3)
3-1 19 333 40 vs 60 25.7 25.7 (22.8–29.0)
3-2 19 433 40 vs 60 24.5 24.5 (22.4–26.9)
3-3 25 333 40 vs 60 23.5 23.5 (22.5–24.6)
3-4 25 433 40 vs 60 25.4 25.4 (22.8–28.2)
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sented method based on a flow cell is shown to be repeatable and suitable for release rate 
evaluation for this type of formulation. The factors with the greatest effects on the release 
method were followed here.
The factor with the greatest influence on the release rate shown was the film thickness, 
as a direct film property; this is good because it shows that the method should express dif-
ferences between formulations. The second-largest effect is related to the donor chamber 
pressure, which can be easily controlled through the height of the levelling beaker. The 
medium flow rate also had a relatively minor effect on the release rate. This is beneficial for 
the reproducibility of the measurements. The importance of the wetting of the films from 
both sides was also discussed to be essential for the discriminatory release testing. This 
method thus provides further advantages over others. It could also be used for film formula-
tions that are releasing the active ingredients from only one side. The drug release condi-
tions of proposed release method do not reflect the in vivo conditions in detail, but the meth-
od was shown to be repeatable and discriminatory for evaluation of film formulations.
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